$ USD Advanced Ophthalmic Equipment Solutions Delivered from Miami EXPLORE EQUIPMENT English
Miis

MiiS AI-DR Diabetic Retinopathy Analysis Software

SKU MIIS-AI-DR

AI-powered retinal image analysis software designed to support diabetic retinopathy screening, lesion identification, referral classification, and ophthalmic telemedicine workflows.

B2B pricing available for clinics, optical stores and distributors. Ships from Miami, FL.

Description

MiiS AI-DR is an artificial intelligence-based retinal image analysis platform developed to assist diabetic retinopathy screening from fundus photographs. The software analyzes retinal images and helps identify findings associated with diabetic retinopathy, including hard exudates, soft exudates, hemorrhages, and microaneurysms.


Depending on the configuration, AI-DR can provide referral classification and diabetic retinopathy severity assessment. The platform supports retinal images with a minimum resolution of approximately 800 × 800 pixels and is compatible with a range of fundus cameras, including the MiiS DEC200.


AI-DR is suitable for ophthalmology clinics, diabetic eye screening programs, telemedicine, primary care, and mobile screening environments where automated retinal image analysis can help streamline clinical workflows.

Technical Specifications

  • AI-based diabetic retinopathy screening
  • Referral classification
  • DR lesion identification
  • Hard exudate detection
  • Soft exudate detection
  • Hemorrhage detection
  • Microaneurysm detection
  • Minimum image resolution: 800 × 800
  • Compatible with multiple fundus camera brands
  • Compatible with MiiS DEC200
  • Supports ophthalmology and telemedicine workflows

Related products